MCK
McKesson Corporation · Healthcare · Medical - Distribution
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 6 | 0 | 804.98K | $699.70M | n/a | n/a |
| Q2 2026 | 172 | 0 | 84.73M | $64.19B | +6 | −5 |
| Q1 2026 | 174 | 0 | 86.49M | $74.72B | +5 | −6 |
| Q4 2025 | 173 | +2 | 91.21M | $74.82B | +3 | n/a |
| Q3 2025 | 22 | 0 | 48.07M | $37.12B | +1 | −2 |
| Q2 2025 | 20 | -1 | 40.25M | $29.48B | n/a | −1 |
| Q1 2025 | 18 | -1 | 15.05M | $10.13B | +1 | −2 |
| Q4 2024 | 19 | +1 | 15.70M | $8.94B | +1 | n/a |
| Q3 2024 | 17 | -1 | 9.08M | $4.48B | +1 | −2 |
| Q2 2024 | 18 | n/a | 11.69M | $6.82B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.63M | n/a | $1.53B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (passive) | 2.28M | n/a | $1.33B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.68M | n/a | $983.61M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 4 | Arrowstreet Capital ✦ | 1.24M | n/a | $721.92M | 0.6% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 857.61K | n/a | $500.88M | 0.8% | n/c | 1 | SEC ↗ ×5 |
| 6 | Wellington Management ✦ | 573.71K | n/a | $335.07M | 0.1% | n/c | 1 | SEC ↗ ×9 |
| 7 | Lone Pine Capital ✦ | 560.94K | n/a | $327.61M | 2.7% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 440.01K | n/a | $256.99M | 0.4% | n/c | 1 | SEC ↗ ×2 |
| 9 | Glenview Capital ✦ | 265.72K | n/a | $155.19M | 3.3% | n/c | 1 | SEC ↗ |
| 10 | Bridgewater Associates ✦ | 257.26K | n/a | $150.25M | 0.8% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 218.43K | n/a | $127.57M | 0.3% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 162.34K | n/a | $94.81M | 0.2% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 144.65K | n/a | $84.48M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 14 | Viking Global Investors ✦ | 142.17K | n/a | $83.03M | 0.3% | n/c | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 127.01K | n/a | $74.18M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 87.28K | n/a | $50.97M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 20.69K | n/a | $12.08M | 0.2% | n/c | 1 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 828 | n/a | $483,914 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,017 holders, 102.83M shares, $85.35B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 800 sh · $797,129
Officer · 111 sh · $98,951
Director · 301 sh · $268,590
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology